Free Trial

LivaNova (LIVN) Competitors

$52.03
+0.60 (+1.17%)
(As of 07/15/2024 ET)

LIVN vs. NTUS, HAE, MASI, TMDX, ITGR, CNMD, SLNO, INMD, BLFS, and AXGN

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Natus Medical (NTUS), Haemonetics (HAE), Masimo (MASI), TransMedics Group (TMDX), Integer (ITGR), CONMED (CNMD), Soleno Therapeutics (SLNO), InMode (INMD), BioLife Solutions (BLFS), and AxoGen (AXGN). These companies are all part of the "medical" sector.

LivaNova vs.

LivaNova (NASDAQ:LIVN) and Natus Medical (NASDAQ:NTUS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, community ranking, valuation, earnings, institutional ownership and dividends.

Natus Medical has a net margin of 2.65% compared to LivaNova's net margin of -2.68%. LivaNova's return on equity of 13.59% beat Natus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova-2.68% 13.59% 7.06%
Natus Medical 2.65%10.15%7.65%

LivaNova has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500. Comparatively, Natus Medical has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500.

LivaNova has higher revenue and earnings than Natus Medical. LivaNova is trading at a lower price-to-earnings ratio than Natus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.15B2.44$17.55M-$0.60-86.72
Natus Medical$473.44M2.41$13.18M$0.3789.08

LivaNova received 257 more outperform votes than Natus Medical when rated by MarketBeat users. However, 82.00% of users gave Natus Medical an outperform vote while only 68.84% of users gave LivaNova an outperform vote.

CompanyUnderperformOutperform
LivaNovaOutperform Votes
380
68.84%
Underperform Votes
172
31.16%
Natus MedicalOutperform Votes
123
82.00%
Underperform Votes
27
18.00%

LivaNova presently has a consensus price target of $66.20, indicating a potential upside of 27.23%. Given LivaNova's higher probable upside, equities research analysts plainly believe LivaNova is more favorable than Natus Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Natus Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

97.6% of LivaNova shares are held by institutional investors. Comparatively, 92.4% of Natus Medical shares are held by institutional investors. 0.3% of LivaNova shares are held by insiders. Comparatively, 1.2% of Natus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, LivaNova had 6 more articles in the media than Natus Medical. MarketBeat recorded 6 mentions for LivaNova and 0 mentions for Natus Medical. Natus Medical's average media sentiment score of 0.59 beat LivaNova's score of 0.36 indicating that Natus Medical is being referred to more favorably in the news media.

Company Overall Sentiment
LivaNova Neutral
Natus Medical Positive

Summary

LivaNova beats Natus Medical on 10 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.82B$2.98B$5.28B$8.54B
Dividend YieldN/A1.76%5.26%4.03%
P/E Ratio-86.727.89127.7616.70
Price / Sales2.4447.962,208.3780.71
Price / Cash11.9570.8532.3731.31
Price / Book2.193.884.944.68
Net Income$17.55M$83.47M$108.27M$214.77M
7 Day Performance0.76%2.94%5.54%5.74%
1 Month Performance-1.23%-4.61%6.09%5.37%
1 Year Performance-1.08%-5.93%6.32%2.93%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NTUS
Natus Medical
0 of 5 stars
0.00 / 5 stars
$32.96
flat
N/A+0.0%$1.14B$473.44M89.081,400
HAE
Haemonetics
3.82 of 5 stars
3.82 / 5 stars
$90.55
+1.2%
$109.50
+20.9%
+7.9%$4.56B$1.31B39.543,657Short Interest ↑
MASI
Masimo
4.6644 of 5 stars
4.66 / 5 stars
$111.96
+0.6%
$143.57
+28.2%
-25.1%$5.92B$1.98B76.165,200
TMDX
TransMedics Group
1.938 of 5 stars
1.94 / 5 stars
$142.19
-1.2%
$133.88
-5.8%
+55.4%$4.68B$241.62M-418.21584Analyst Forecast
ITGR
Integer
1.8257 of 5 stars
1.83 / 5 stars
$120.23
+2.5%
$128.00
+6.5%
+43.7%$4.03B$1.60B41.6010,500Short Interest ↓
CNMD
CONMED
4.9839 of 5 stars
4.98 / 5 stars
$68.40
+0.9%
$102.50
+49.9%
-49.3%$2.11B$1.24B26.214,100Positive News
SLNO
Soleno Therapeutics
3.2207 of 5 stars
3.22 / 5 stars
$47.67
+7.1%
$60.33
+26.6%
+786.1%$1.59BN/A-17.7933Gap Up
INMD
InMode
2.1355 of 5 stars
2.14 / 5 stars
$17.87
+6.2%
$31.60
+76.8%
-60.2%$1.50B$492.05M8.47581Analyst Forecast
Short Interest ↑
News Coverage
BLFS
BioLife Solutions
1.0968 of 5 stars
1.10 / 5 stars
$20.72
-1.2%
$23.67
+14.2%
+5.6%$954.57M$143.27M-14.59409Positive News
AXGN
AxoGen
2.0811 of 5 stars
2.08 / 5 stars
$8.26
-0.8%
$12.25
+48.3%
-6.3%$361.05M$159.01M-16.52450Short Interest ↑
News Coverage

Related Companies and Tools

This page (NASDAQ:LIVN) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners